Великие по собственному выбору - Мортен Хансен

15. “Robert A. Swanson 70 (1947–1999),” MIT Entrepreneurship Center-Legendary Leaders and Memorials, http://entrepreneurship.mit.edu/legendary_leaders_memorials.php; “Timeline of Biotechnology,” Biotechnology Institute, http://www.biotechinstitute.org/what-is-biotechnology/timeline?tid=103.

16. Ray Snoddy, “Genentech Push to Manufacturing,” Financial Times, June 18, 1982, 13; William D. Marbach, Pamela Abramson, Robb A. Allan, Cynthia Rigg, and Phyllis Malamud, “The Bust in Biotechnology,” Newsweek, July 26, 1982, 73; Peter Behr, “Boom or Bust in the Biotech Industry,” Environment, July/August 1982, 6; Genentech Inc., Fiscal 1985 Annual Report (San Francisco: Genentech Inc., 1985).

17. Jerry E. Bishop, “Genentech Seeks Human Tests of Drug to Dissolve Clots During Heart Attacks,” Wall Street Journal, November 16, 1983, 60; “Licensing of Activase Marks New Era in Treating Heart Attacks,” Genentech, Inc. Press Releases, November 13, 1987, http://www.gene.com/gene/news/press-releases/display.do?method=detail&id=4271; Marilyn Chase, “Genentech Expected to Post Strong Net for 1987, Spurred by Launch of TPA,” Wall Street Journal, January 12, 1988, 1.

18. Nell Henderson, “Biotech Breakthrough Focuses on Heart Attacks; Survival Tech Works on Delivering New Drug,” Washington Post, October 12, 1986, HI.

19. Andrea Gabor and Peter Dworkin, “Superdrugs from Genetic Secrets,” U. S. News & World Report, March 24, 1986, 54; Joan O’C. Hamilton, “Biotech’s First Superstar,” Business Week, April 14, 1986, 68; Louise Kehoe, “Fresh Blood and New Heart; Eagle Eye,” Financial Times, January 19, 1988, 32.

20. The TIMI Study Group, “Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction,” New England Journal of Medicine, March 9, 1989, 320, 618–27; Lawrence K. Altman, “Study Finds No Difference in 2 Heart Attach [sic] Drugs,” New York Times, March 30, 1989; Michael Waldholz, “Genentech Heart Drug Dealt Critical Blow-Head to Head Study Finds TPA Is Only As Effective As Rival Streptokinase,” Wall Street Journal, March 30, 1989.

21. Michael Waldholz, “Heart Attack Study May Spur Use of Less-Costly TPA Alternative,” Wall Street Journal, August 12, 1988, 1; Richard L. Hudson, “Genentech’s Heart Drug TPA Appears Only to Equal Its Rivals, Report Says,” Wall Street Journal, September 2, 1988, 1; Marilyn Chase, “Lost Euphoria: Genentech, Battered by Great Expectations, Is Tightening Its Belt,” Wall Street Journal, October 11, 1988, 1; Marilyn Chase, “Little Difference is Found Between TPA and Rival in Small Study of Heart Drugs,” Wall Street Journal, November 14, 1988, 1; Michael Waldholz, “Genentech Heart Drug Dealt Critical Blow – Head to Head Study Finds TPA Is Only As Effective As Rival Streptokinase,” Wall Street Journal, March 30, 1989, 1; “Genentech’s Fortunes: A Boost for CD4 and ’Crosscurrents’ in 1988,” Pharmaceutical Business News, April 14, 1989; Sabin Russell, “Heart-Attack Drug Study is a Blow to Genentech,” San Francisco Chronicle, March 9, 1990, Al; “Heart-Attack Drugs: Trials and Tribulations,” Economist, March 16, 1991, 86; Genentech Inc., Fiscal 1989 Annual Report (San Francisco: Genentech Inc., 1989).

22. Charles Petit, “Genentech Beats Cheaper Rival in Battle of Heart Attack Drugs,” San Francisco Chronicle, May 1, 1993, Al; Genentech Inc., Fiscal 1994 Annual Report (San Francisco: Genentech Inc., 1994).

200

Gene Bylinsky, “How Intel Won Its Bet on Memory Chips,” Fortune, November 1973, 184; Thomas C. Hayes, “Intel’s Earnings Grew Sharply in Fourth Quarter,” New York Times, January 14, 1984.

201

Gordon M. Binder, Amgen (n.p.: The Newcomen Society of the United States, 1998), 10.

202

James Bates, “Biotech Detective Scores Coup: Amgen Scientist Spent Years Searching for the Key to Producing EPO,” Los Angeles Times, June 2, 1989, 1; David Ewing Duncan, The Amgen Story: 25 Years of Visionary Science and Powerful Medicine (San Diego: Tehabi Books, 2005), 66, 71; Edmund L. Andrews, “Mad Scientists,” Business Month, May 1990, 54; Pamela Sherrid, “Biotech Battle Royale,” U. S. News 6 World Report, March 20, 2000, 52; “Billion Dollar Babies: Biotech Drugs as Blockbusters,” Nature Biotechnology, April 2007.

203

White, Weld & Co. and McDonald & Company, “Prospectus: The Progressive Corporation Common Stock,” The Progressive Corporation, April 15, 1971; April Dougal Gasbarre (updated by David Bianco), “The Progressive Corporation,” International Directory of Company Histories (New York: St. James Press, 1999), 397; The Progressive Corporation, Fiscal 2000 Annual Report (Mayfield Village, OH: The Progressive Corporation, 2000).

204

James Wallace and Jim Erickson, Hard Drive (New York: Harper-Business, 1992), 20, 27, 53, 67, 71–76.

205

According to Table 1, page 23, in the Bukoski and Korotkin article cited here, in 1970, 3.9 percent of U.S. public secondary schools used computers for instruction. William J. Bukoski and Arthur L. Korotkin, “Computing Activities in Secondary Education,” American Institutes for Research in the Behavioral Sciences, September 1975, 2–30; Andrew Molnar, “Computers in Education: A Brief History,” THE Journal, June 1, 1997.

206

Andrew Molnar, “Computers in Education: A Brief History,” THE Journal, June 1, 1997.

207

James Wallace and Jim Erickson, Hard Drive (New York: Harper-Business, 1992), 76–77, 97, 110.

208

Jeffrey L. Rodengen, The Spirit of AMD: Advanced Micro Devices (Ft. Lauderdale, FL: Write Stuff Enterprises Inc., 1998), 127; Stephen Kreider Yoder, “Changing Game: Intel Faces Challenge to Its Dominance in Microprocessors,” Wall Street Journal, April 8, 1991, Al; Ken Siegmann, “Intel Loses Copyright Suit Against Rival,” San Francisco Chronicle, March 11, 1994, Al; Jim Carlton and Stephen Kreider Yoder, “Computers: Humble Pie: Intel to Replace its Pentium Chips,” Wall Street Journal, December 21, 1994, Bl; Don Clark, “Intel’s 4th Period Net Fell 37 % on Big Charge for Pentium Woes,” Wall Street Journal, January 18, 1995, B6; Stewart Alsop and Patty de Llosa, “Can AMD Avoid the Intel Graveyard?” Fortune, April 14, 1997; Ira Sager and Andy Reinhardt, “Chipping at Intel’s Lead,” Business Week, October 19, 1998, 46; Advanced Micro Devices, Fiscal 1994 and 1998 Annual Reports (Sunnyvale, VA: Advanced Micro Devices, 1994 and 1998.

209

Advanced Micro Devices, Fiscal 1995 Annual Report (Sunnyvale, VA: Advanced Micro Devices, 1995); Jeffrey L. Rodengen, The Spirit of AMD: Advanced Micro Devices (Ft. Lauderdale, FL: Write Stuff Enterprises Inc., 1998), 133–36.

210

Jim Carlton, “Advanced Micro Woos a Partner to Fight Intel,” Wall Street Journal, October 23, 1995, A3; Robert D. Hof and Peter Burrows, “Intel Won’t Feel the Heat from this Fusion,” Business Week, November 6, 1995; “My Chip is Faster than Your Chip,” Business Week, February 10, 1997, 70; “Advanced Micro Lands Deal with Digital,” Dow Jones Online News, April 25, 1997; Jeffrey L. Rodengen, The Spirit of AMD: Advanced Micro Devices (Ft. Lauderdale, FL: Write Stuff Enterprises Inc., 1998), 137–39; Ira Sager and Andy Reinhardt, “Chipping at Intel’s Lead,” Business Week, October 19,1998,46; “Semiconductors: The Monkey and the Gorilla,” Economist, December 5, 1998, 71.

211

Dean Takahashi, “More Bad News Puts Intel Rival Further Behind,” Wall Street Journal, June 24, 1999, Bl; Angela Key, “Hello (Again), Mr. Chips,” Fortune, April 3, 2000; “Semiconductors: The Monkey and the Gorilla,” Economist, December 5, 1998, 71; Jeffrey L. Rodengen, The Spirit of AMD: Advanced Micro Devices (Ft. Lauderdale, FL: Write Stuff Enterprises Inc., 1998), 133–36, 141.

212

James Wallace and Jim Erickson, Hard Drive (New York: Harper-Business, 1992), 167, 173, 175–77, 179–81; Lisa Miller Mesdag, “Famous Victories in Personal Software,” Fortune, May 2, 1983, 153; Julia Pitta, “Coulda Been a Contender,” Forbes, July 10, 1989; John Markoff, “PC Software Maker Novell to Buy Digital Research,” New York Times, July 17, 1991.

213

James Wallace and Jim Erickson, Hard Drive (New York: Harper-Business, 1992) 176, 190; Lisa Miller Mesdag, “Famous Victories in Personal Software,” Fortune, May 2, 1983, 153; Julia Pitta, “Coulda Been a Contender,” Forbes, July 10, 1989.

214

Marcia Stepanek, “Q&A with Progressive’s Peter Lewis,” Business Week, September 12, 2000; “About Us: Provisions of Proposition 103 Affecting the Rate Regulation Division,” California Department of Insurance, http://www.insurance.ca.gov/0500-about-us/0500-organization/0400-rate-regulation/prop-103.cfm; The Progressive Corporation, Fiscal 1991 Annual Report (Mayfield Heights, OH: The Progressive Corporation, 1991).

215

Stephen Phillips, “Driven to Succeed Peter Lewis, Progressive’s Artful Chief Exec, Aims to Overtake Auto Insurance Industry’s Leaders,” Plain Dealer, September 1, 1996, 1.1; “Ralph Nader Biography,” Academy of Achievement, http://www.achievement.org/autodoc/page/nadObio-l; James Wallace and Jim Erickson, Hard Drive (New York: Harper-Business, 1992), 76; Brian Dumaine, “Times are Good? Create a Crisis,” Fortune, June 28, 1993, 123; David Craig, “Progressively Thinking,” USA Today, September 15, 1994, 01.B; Carol J. Loomis, “Sex. Reefer? And Auto Insurance!” Fortune, August 7, 1995, 76.

216

Betsy Wiesendanger, “Progressive’s Success is No Accident,” Sales & Marketing Management, September 1991, 57; Ronald Henkoff, “Service is Everybody’s Business,” Fortune, June 27, 1994, 48; Carol J. Loomis, “Sex. Reefer? And Auto Insurance!” Fortune, August 7, 1995, 76; “Leading Writers of Private Passenger Auto Insurance,” Best’s Review, September 1988, 22; “All Private Passenger Auto,” Best’s Review, October 1998; “Gearing Up: Insurers are Using Driver Safety Programs, Sharply Focused Advertising and the Internet to Court Teen Drivers,” Best’s Review, October 2003; Chuck Salter, “Progressive Makes Big Claims,” Fast Company, November 1998, 176.

217

Malcolm Gladwell, Outliers, paperback edition (New York: Back Bay Books/Little Brown and Company, 2011), 20–30.

218